What is partial response vs complete response in MDS treatment
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Partial Response vs Complete Response in MDS Treatment
Great question! These terms describe how well a patient's MDS is responding to treatment, and they're important for tracking whether therapy is working.
Complete Response (CR)
A complete response means the disease has essentially disappeared or normalized. In MDS specifically, this means:
- Blood counts return to normal ranges – your red blood cells, white blood cells, and platelets are all healthy
- No dysplasia – the abnormal-looking cells (dysplasia) that characterize MDS are no longer visible under the microscope
- Bone marrow blasts are normal – the immature blood cells are at healthy levels (less than 5%)
- No cytogenetic abnormalities – chromosomal problems that were present are no longer detectable
Complete response is the "best case scenario" – it means your MDS has responded very well to treatment.
Partial Response (PR)
A partial response means the disease has improved significantly, but hasn't completely normalized. This includes:
- Meaningful improvement in blood counts – your hemoglobin, white blood cells, or platelets improve substantially (though may not reach completely normal levels)
- Reduction in blasts – the percentage of immature cells decreases noticeably
- Reduced transfusion needs – if you were requiring regular blood transfusions, you may need fewer
- Improvement in dysplasia – abnormal cells decrease, though some may still be present
Partial response is still considered a good outcome – it means treatment is working, even if it hasn't completely eliminated the disease.
Why This Matters for Your Care
According to the NCCN Guidelines for Myelodysplastic Syndromes, doctors evaluate treatment response using the International Working Group (IWG) criteria to determine whether to:
- Continue current treatment if you're responding well
- Adjust the dose if side effects are problematic
- Switch treatments if there's no response within 3-6 months
- Consider additional options like stem cell transplant for certain patients
Questions to Ask Your Doctor
- What type of response are we aiming for with my specific MDS? (Some lower-risk cases may target partial response; higher-risk cases may pursue complete response)
- How will you measure my response? (Blood tests, bone marrow biopsy, genetic testing?)
- What timeline should we expect to see a response? (Usually 3-6 months)
- What happens if I achieve partial response but not complete response? (Is that acceptable, or will we adjust treatment?)
- How often will we reassess my response? (Monitoring schedule)
Key Point
Both complete and partial responses indicate that your treatment is working. Your doctor will help determine which level of response is realistic and appropriate for your specific MDS type, risk category, and overall health situation.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Myelodysplastic Syndromes (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for MDS patients
Have your records handy? Upload them for a deeper, personalized analysis →